TY  - JOUR

T1  - Cabozantinib and axitinib after vascular endothelial growth factor therapy in patients with advanced renal cell carcinoma: a retrospective cohort study from England

JO  - Drugs - Real World Outcomes

UR  - https://eprints.whiterose.ac.uk/id/eprint/210715

PY  - 2024/01/24

AU  - Brown J

AU  - Harrow B

AU  - Marciniak A

AU  - McCarthy C

AU  - Houchard A

AU  - Cirneanu L

AU  - Protheroe A

ED  - 

DO  - DOI: 10.1007/s40801-023-00415-w

PB  - Springer Science and Business Media LLC

VL  - 11

IS  - 2

SP  - 195

EP  - 207

Y2  - 2025/12/05

ER  -